Insights Center
ML Strategies Viewpoints
Search
Showing 57 - 64 of 492 results
ML Strategies Capitol Hill & Executive Branch Fall Preview
September 6, 2018
ML Strategies Health Care Preview – Week of September 4th
September 4, 2018|Blog
President Signs Legislation Reforming CFIUS & Export Controls
August 28, 2018|Alert
ML Strategies Weekly Health Care Preview – July 30, 2018
July 30, 2018|Blog
ML Strategies Weekly Health Care Preview – July 23, 2018
July 23, 2018|Blog
ML Strategies Health Care Preview – July 16, 2018
July 16, 2018|Blog
ML Strategies Weekly Health Care Preview – July 9, 2018
July 9, 2018|Blog
Massachusetts Legislature Strikes “Grand Bargain”
June 26, 2018|Alert
News & Press Releases
To Pitch Pre-Cert to Congress, FDA Builds a Case First
September 26, 2019 | MedTechDive
MedTechDive reported that the U.S. Food and Drug Administration is not yet ready to go to Congress to seek new powers for its evolving precertification pilot for software, but it will need new authorities to determine how the experimental path fits into the current regulatory scheme. The article included commentary from Senior Director of ML Strategies Aaron Josephson and Mintz Associate Benjamin Zegarelli.
Former FDAer Defends FDA Decision to Withdraw Data Falsification Rule
August 20, 2019 | Inside Health Policy
An article published by Inside Health Policy quoted Aaron Josephson, Senior Director at ML Strategies, extensively in response to recent debate surrounding the U.S. Food and Drug Administration’s proposed rule “Reporting Information Regarding Falsification of Data,” which was previously withdrawn.
Events
Nov
8
2019